Delta Infection After Vaccination Elicits Potent Neutralizing Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron

被引:3
|
作者
Zhu, Ka-Li [1 ,2 ]
Gao, Hui-Xia [3 ]
Yao, Lin [2 ]
Rong, Jun [3 ]
Yang, Li [3 ]
Zhang, Zhi [3 ]
Jiang, Ping [3 ]
Duan, Li-Jun [2 ]
Wang, Guo-Lin [2 ]
Dai, Er-Hei [3 ]
Ma, Mai-Juan [1 ,2 ]
机构
[1] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Peoples R China
[2] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, 20 Dongda St, Beijing 100071, Peoples R China
[3] Hebei Med Univ, Hosp Shijiazhuang 5, Shijiazhuang, Hebei, Peoples R China
基金
北京市自然科学基金;
关键词
SARS-CoV-2; Delta infection; Omicron; vaccination; neutralization;
D O I
10.1093/infdis/jiac149
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant extensively escape neutralizing antibodies by vaccines or infection. We assessed serum neutralizing activity in sera from Delta infection after vaccination and Delta infection only against SARS-CoV-2 Wuhan-Hu-1 (WA1), Beta, Delta, and Omicron. Sera from Delta infection only could neutralize WA1 and Delta but almost completely lost capacity to neutralize Beta and Omicron. However, Delta infection after vaccination resulted in a significant increase of serum neutralizing activity against WA1, Beta, and Omicron. This study demonstrates that breakthrough infection of Delta substantially induced high potency humoral immune response against the Omicron variant and other emerged variants. The sera from patients with the Delta infection only had less neutralizing activity to the Omicron, whereas the sera from patients with Delta infection after vaccination displayed potent neutralization to the Omicron variant.
引用
收藏
页码:1551 / 1555
页数:5
相关论文
共 50 条
  • [1] Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection
    Gaebler, Christian
    DaSilva, Justin
    Bednarski, Eva
    Muecksch, Frauke
    Schmidt, Fabian
    Weisblum, Yiska
    Millard, Katrina G.
    Turroja, Martina
    Cho, Alice
    Wang, Zijun
    Caskey, Marina
    Nussenzweig, Michel C.
    Bieniasz, Paul D.
    Hatziioannou, Theodora
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (07):
  • [2] Acute Genital Ulceration After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination and Infection
    Hsu, Tina
    Sink, Jacquelyn R.
    Alaniz, Veronica, I
    Zheng, Lida
    Mancini, Anthony J.
    JOURNAL OF PEDIATRICS, 2022, 246 : 271 - 273
  • [3] Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection
    Froberg, Janeri
    Diavatopoulos, Dimitri A.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2021, 34 (03) : 181 - 186
  • [4] Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses
    Lawrenz, Jan
    Xie, Qinya
    Zech, Fabian
    Weil, Tatjana
    Seidel, Alina
    Krnavek, Daniela
    van der Hoek, Lia
    Muench, Jan
    Mueller, Janis A.
    Kirchhoff, Frank
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E653 - E661
  • [5] Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Neutralization After Antenatal Messenger RNA Vaccination
    Rottenstreich, Amihai
    Vorontsov, Olesya
    Alfi, Or
    Zarbiv, Gila
    Oiknine-Djian, Esther
    Zigron, Roy
    Kleinstern, Geffen
    Mandelboim, Michal
    Porat, Shay
    Wolf, Dana G.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (11) : 2023 - 2026
  • [6] Description of Hospitalizations due to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Based on Vaccination Status
    Moffa, Matthew A.
    Shively, Nathan R.
    Carr, Dustin R.
    Bremmer, Derek N.
    Buchanan, Carley
    Trienski, Tamara L.
    Jacobs, Max W.
    Saini, Vikram
    Walsh, Thomas L.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (09):
  • [7] Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus Vaccination in Pregnancy: Implications for Maternal and Infant Immunity
    Conti, Maria Giulia
    Terreri, Sara
    Terrin, Gianluca
    Natale, Fabio
    Pietrasanta, Carlo
    Salvatori, Guglielmo
    Brunelli, Roberto
    Midulla, Fabio
    Papaevangelou, Vassiliki
    Carsetti, Rita
    Angelidou, Asimenia
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (SUPPL 1) : S37 - S45
  • [8] Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
    Luczkowiak, Joanna
    Radreau, Pauline
    Nguyen, Ludovic
    Labiod, Nuria
    Lasala, Fatima
    Veas, Francisco
    Herbreteau, Cecile Helene
    Delgado, Rafael
    JOURNAL OF INFECTIOUS DISEASES, 2022, 227 (01) : 35 - 39
  • [9] Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following Prior Infection or Vaccination
    Ebinger, Joseph E.
    Sun, Nancy
    Joung, Sandy Y.
    Sanchez, John Michael S.
    Wang, Minhao
    Liu, Yunxian
    Prostko, John C.
    Frias, Edwin C.
    Stewart, James L.
    Heath, Mallory
    Claggett, Brian L.
    Cheng, Susan
    Sobhani, Kimia
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (03) : E584 - E590
  • [10] Association of sleep duration and quality with immunological response after vaccination against severe acute respiratory syndrome coronavirus-2 infection
    Athanasiou, Nikolaos
    Baou, Katerina
    Papandreou, Eleni
    Varsou, Georgia
    Amfilochiou, Anastasia
    Kontou, Elisavet
    Pataka, Athanasia
    Porpodis, Konstantinos
    Tsiouprou, Ioanna
    Kaimakamis, Evangelos
    Kotoulas, Serafeim-Chrysovalantis
    Katsibourlia, Evgenia
    Alexopoulou, Christina
    Bouloukaki, Izolde
    Panagiotarakou, Meropi
    Dermitzaki, Aspasia
    Charokopos, Nikolaos
    Pagdatoglou, Kyriakh
    Lamprou, Kallirroi
    Pouriki, Sofia
    Chatzivasiloglou, Foteini
    Nouvaki, Zoi
    Tsirogianni, Alexandra
    Kalomenidis, Ioannis
    Katsaounou, Paraskevi
    Vagiakis, Emmanouil
    JOURNAL OF SLEEP RESEARCH, 2023, 32 (01)